Haisco Pharmaceutical Group Co.,Ltd — Investor Relations & Filings
Haisco Pharmaceutical Group Co.,Ltd. focuses on the research, development, production, and commercialization of innovative drugs and high-end generic pharmaceuticals. The company maintains a specialized portfolio across therapeutic areas including anesthesia, parenteral nutrition, anti-infection, cardiovascular health, and endocrine disorders. Key products include advanced anesthetic agents and specialized nutritional injections designed for clinical use. Haisco prioritizes technological innovation through a dedicated R&D infrastructure, targeting the development of small molecule chemical drugs and complex delivery systems. Its operations emphasize high-standard manufacturing processes and the integration of clinical research to address complex medical requirements. The company aims to provide therapeutic solutions that enhance patient care through a commitment to scientific excellence and product quality.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于控股股东部分股份质押展期的公告 | 2026-01-13 | Chinese | |
| 关于修订《公司章程》的公告 | 2026-01-09 | Chinese | |
| 关于召开2026年第一次临时股东会通知的公告 | 2026-01-09 | Chinese | |
| 第五届董事会第三十四次会议决议公告 | 2026-01-09 | Chinese | |
| 中信证券股份有限公司关于海思科医药集团股份有限公司使用闲置募集资金进行现金管理的核查意见 | 2026-01-09 | Chinese | |
| 关于与AirNexis签署HSK39004项目授权许可协议暨关联交易的公告 | 2026-01-09 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
11 filings
| |||||
| 36672942 | 关于控股股东部分股份质押展期的公告 | 2026-01-13 | Chinese | ||
| 36672935 | 关于修订《公司章程》的公告 | 2026-01-09 | Chinese | ||
| 36672932 | 关于召开2026年第一次临时股东会通知的公告 | 2026-01-09 | Chinese | ||
| 36672925 | 第五届董事会第三十四次会议决议公告 | 2026-01-09 | Chinese | ||
| 36672917 | 中信证券股份有限公司关于海思科医药集团股份有限公司使用闲置募集资金进行现金管理的核查意见 | 2026-01-09 | Chinese | ||
| 36672911 | 关于与AirNexis签署HSK39004项目授权许可协议暨关联交易的公告 | 2026-01-09 | Chinese | ||
| 36672908 | 公司章程（2026年1月） | 2026-01-09 | Chinese | ||
| 36672904 | 关于使用闲置募集资金进行现金管理的公告 | 2026-01-09 | Chinese | ||
| 36672894 | 关于获得创新药HSK39297片上市许可《受理通知书》的公告 | 2026-01-06 | Chinese | ||
| 36672887 | 第五届董事会第三十三次会议决议公告 | 2026-01-05 | Chinese | ||
| 36672875 | 关于注销控股子公司暨关联交易的公告 | 2026-01-05 | Chinese | ||
|
2025
4 filings
| |||||
| 36672811 | 关于获得创新药IND申请《受理通知书》的公告 | 2025-12-30 | Chinese | ||
| 36672809 | 关于获得创新药HSK44459片新增适应症《药物临床试验批准通知书》的公告 | 2025-12-30 | Chinese | ||
| 36672802 | 关于向特定对象发行股票提交募集说明书（注册稿）等申请文件的提示性公告 | 2025-12-22 | Chinese | ||
| 36672795 | 中信证券股份有限公司关于海思科医药集团股份有限公司向特定对象发行A股股票之发行保荐书 | 2025-12-22 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Haisco Pharmaceutical Group Co.,Ltd via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/54674/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=54674 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=54674 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=54674 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 54674}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Haisco Pharmaceutical Group Co.,Ltd (id: 54674)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.